Commentary Volume 22 Issue 3 - 2023
Puerile and Forager-Blastic Plasmacytoid Dendritic Cell Neoplasm
Department of Histopathology, Panjab University, A.B. Diagnostics, India
*Corresponding
Author: Anubha Bajaj, Department of Histopathology, Panjab University, A.B. Diagnostics, India.
Received: February 08, 2023; Published: February 22, 2023
Blastic plasmacytoid dendritic cell neoplasm is an exceptional malignant haematological disorder derived from plasmacytoid dendritic cells (pDC). Non neoplastic counterpart of the malignant condition is configured from plasmacytoid dendritic cells.
Blastic plasmacytoid dendritic cell neoplasm is additionally designated as blastic natural killer (NK) lymphoma, agranular CD4+/CD56+ hematodermic neoplasm, agranular CD4+ NK cell leukaemia or CD56+ TdT+ blastic NK cell lymphoma.
- Adimora IJ., et al. “Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics”. Cancer16 (2022): 3019-3026.
- Khoury JD. “Blastic Plasmacytoid Dendritic Cell Neoplasm”. Current Hematologic Malignancy Reports 6 (2018): 477-483.
- Trottier AM., et al. “Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects”. Blood and Lymphatic Cancer 7 (2017): 85-93.
- Cheng W., et al. “Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches”. Current Medical Science 3 (2021): 405-419.
- Zhang X., et al. “New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm”. Critical Reviews in Oncology/Hematology 149 (2020): 102928.
- Image 1 Courtesy: Science direct.
- Image 2 Courtesy: Nature.
Anubha Bajaj. “Puerile and Forager-Blastic Plasmacytoid Dendritic Cell Neoplasm”.”. EC Dental Science 22.3 (2023): 91-95.
© 2023 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by ECronicon is
licensed under a Creative Commons Attribution
4.0 International License
Based on a work at www.ecronicon.org